{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:26:31Z","timestamp":1767871591648,"version":"3.49.0"},"reference-count":24,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s541723","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:45:12Z","timestamp":1767858312000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Research Status of Androgen Deprivation Therapy Monotherapy and Combination Therapy for Prostate Cancer: A Scoping Review"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Xiaolin","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"ref1","unstructured":"Cancer TODAY | IARC -Data version: globocan 2022 (version 1.1.) Incidence in the World. 2022."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn112152-20240119-00035","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40779-025-00599-y","volume":"12","author":"Feng","year":"2025","journal-title":"Military Med Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.6004\/jnccn.2019.5011","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"ref8","unstructured":"FDA. FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-enzalutamide-non-metastatic-castration-sensitive-prostate-cancer-biochemical-recurrence2023. Accessed December 24, 2025."},{"key":"ref9","unstructured":"Society Ac. Treating prostate cancer. 2023."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jclinepi.2020.03.016","volume":"123","author":"McGowan","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/bju.14768","volume":"125","author":"Sargos","year":"2020","journal-title":"BJU Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2165\/00003495-199448060-00008","volume":"48","author":"Plosker","year":"1994","journal-title":"Drugs"},{"key":"ref13","volume":"15","author":"Zhipeng Wang","year":"2025","journal-title":"J Pharm Anal"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur Urol"},{"key":"ref15","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology: prostate cancer (version 4 2024). 2024."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/iju.13380","volume":"24","author":"Kakehi","year":"2017","journal-title":"Int J Urol"},{"key":"ref18","unstructured":"Oncology PCECotCSoC. CSCO guidelines for the treatment of prostate cancer 2022. 2022."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/ajco.14101","volume":"20","author":"Matveev","year":"2024","journal-title":"Asia-Pac J Clini Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ajur.2019.09.003","volume":"7","author":"Sun","year":"2020","journal-title":"Asian J Urol"},{"key":"ref21","first-page":"49","volume":"21","author":"He","year":"2007","journal-title":"Chin J Androl"},{"key":"ref22","first-page":"1177","volume":"37","author":"Yang","year":"2017","journal-title":"Tumor"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.12669\/pjms.35.5.591","volume":"35","author":"Zhang","year":"2019","journal-title":"Pak J Med Sci"},{"key":"ref24","first-page":"922","volume":"23","author":"Zhang","year":"2017","journal-title":"Zhonghua Nan Ke Xue"}],"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/110799","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/110799","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:45:15Z","timestamp":1767858315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/research-status-of-androgen-deprivation-therapy-monotherapy-and-combin-peer-reviewed-fulltext-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2147\/cmar.s541723","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}